(firstQuint)Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder.

 Tourette's Disorder is a neuropsychiatric condition that is characterized by the appearance of tics that can be simple or complex in nature.

 A tic is a sudden, rapid, recurrent, non-rhythmic, stereotyped motor movement or vocalization.

 There are a very limited number of medications approved for the treatment of Tourette's Disorder.

 The goal of the current trial is to obtain additional efficacy, safety, and tolerability data in a controlled condition of a Once-daily aripiprazole formulation in children and adolescents with Tourette's Disorder.

 The trial is a 52-week extension to the double-blind trial.

 The Once-daily tablet formulation that will be evaluated in this trial represents a daily dosage regimen that is intended to be administered to children and adolescents.

.

 Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder@highlight

The goal of the current trial is to determine safety of Once-daily aripiprazole in reducing Total Tic Severity in children and adolescents with Tourette's Disorder.

